[HTML][HTML] Risk SNP-mediated promoter-enhancer switching drives prostate cancer through lncRNA PCAT19
The prostate cancer (PCa) risk-associated SNP rs11672691 is positively associated with
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19
JT Hua, M Ahmed, H Guo, Y Zhang, S Chen… - …, 2018 - mayoclinic.elsevierpure.com
The prostate cancer (PCa) risk-associated SNP rs11672691 is positively associated with
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19.
JT Hua, M Ahmed, H Guo, Y Zhang, S Chen, F Soares… - Cell, 2018 - europepmc.org
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA
PCAT19. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
PCAT19. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …
[引用][C] Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19
JT Hua, M Ahmed, H Guo, Y Zhang, S Chen, F Soares… - Cell, 2018 - cir.nii.ac.jp
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA
PCAT19 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ移動 検索 …
PCAT19 | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲ恁縖サイニィ] 詳細へ移動 検索 …
[PDF][PDF] Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19
JT Hua, M Ahmed, H Guo, Y Zhang, S Chen, F Soares… - Cell, 2018 - academia.edu
The prostate cancer (PCa) risk-associated SNP rs11672691 is positively associated with
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19
JT Hua, M Ahmed, H Guo - Cell, 2018 - dialnet.unirioja.es
The prostate cancer (PCa) risk-associated SNP rs11672691 is positively associated with
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
[HTML][HTML] Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19
JT Hua, M Ahmed, H Guo, Y Zhang, S Chen, F Soares… - Cell, 2018 - Elsevier
The prostate cancer (PCa) risk-associated SNP rs11672691 is positively associated with
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
Risk SNP-Mediated Promoter-Enhancer Switching Drives Prostate Cancer through lncRNA PCAT19
JT Hua, M Ahmed, H Guo, Y Zhang, S Chen… - Cell, 2018 - pubmed.ncbi.nlm.nih.gov
The prostate cancer (PCa) risk-associated SNP rs11672691 is positively associated with
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
aggressive disease at diagnosis. We showed that rs11672691 maps to the promoter of a …
